Low-dose rabbit antithymocyte globulin versus basiliximab induction therapy in low-risk renal transplant recipients: 8-year follow-up

Transplantation Proceedings

Volumn 43, Issue 2, 2011, Pages 458-461

  Laftavi, M R ^a,b   Alnimri, M ^a   Weber Shrikant, E ^a   Kohli, R ^a   Said, M ^a   Patel, S ^a   Pankewycz, O ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASILIXIMAB; CREATININE; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; CONFERENCE PAPER; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; MAINTENANCE THERAPY; MALE; PRIORITY JOURNAL; RECIPIENT; RISK BENEFIT ANALYSIS;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTILYMPHOCYTE SERUM; CADAVER; CREATININE; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; NEOPLASMS; RABBITS; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES;

EID: 79953194470     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.01.035     Document Type: Conference Paper

References (23)

1. S. Hariharan, C.P. Johnson, and B.A. Bresnahan Improved graft survival after renal transplantation in the United States, 1988 to 1996 N Eng J Med 342 2000 605
2. S. Hariharan Long-term kidney transplant survival Am J Kidney Dis 386 suppl 6 2001 S44
3. J. Gralla The impact if IL2Ra induction therapy in kidney transplantation using tacrolimus and mycophenolate based immunosuppression Transplantation 90 2010 639
4. M.C.R. Castro, L.M.P. Araujo, and W.N. Nahas Induction versus non induction therapy in kidney transplantation, considering different PRA levels, and different induction therapies Transplant Proc 36 2004 874
5. F. Ferrer, S. Machado, and R. Alves Induction with basiliximab in renal transplantation Transplant Proc 42 2010 467
6. K. McKeage, and P.L. Mccormack Basiliximab a review of its use as induction therapy in renal transplantation BioDrugs 24 2010 55
7. P. Leendert Chronic allograft nephropathy, a model of impaired repair from injury Nephrol Dial Transplant 15 2000 149
8. D.C. Brennan, and M.A. Schnitzler Long term results of rabbit anti thymocyte globulin and basiliximab induction N Engl J Med 359 2008 1736
9. D.C. Brennan, J. Daller, and K. Lake Rabbit antithymocyte globulin vs. basiliximab in renal transplantation N Engl J Med 355 2006 1967
10. P. Clesca, M. Derlando, and S.I. Park Thymoglobulin and rate of infectious complications post transplantation Transplant Proc 39 2007 463
11. Thymoglobulin package insert 2008 Genzyme Corporation Cambridge, MA
12. M. Buchler, B. Hurault de Ligny, and C. Madec Induction therapy by anti-thymocyte globulin (rabbit) in renal transplantation: A 1-yr follow-up of safety and efficacy Clin Transplant 17 2003 539
13. A. Djamali, C. Turc-Baron, and P. Portales Low dose antithymocyte globulins in renal transplantation: daily versus intermittent administration based on T-cell monitoring Transplantation 69 2000 799
14. I.A. Agha, J. Rueda, and A. Alvarez Short course induction immunosuppression with thymoglobulin for renal transplant recipients Transplantation 73 2002 473
15. K.L. Hardinger, M.A. Schnitzler, and M.J. Koch Thymoglobulin induction is safe and effective in live- donor renal transplantation: a single center experience Transplantation 81 2006 1285
16. R.B. Stevens, D.F. Mercer, and W.J. Grant Randomized trial of single-dose versus divided-dose rabbit anti-thymocyte globulin induction in renal transplantation: an interim report Transplantation 85 2008 1391
17. E.D. Deeks, and G.M. Keating Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection Drugs 69 2009 1483
18. I. Fuks, D. Shitrit, and B.D. Fox Herpes zoster after lung transplantation: incidence, timing, and outcome Ann Thorac Surg 87 2009 423
19. T.M. Chapman, and G.M. Keating Basiliximab: a review of its use as induction therapy in renal transplantation Drugs 63 2003 2803
20. O. Pankewycz, R. Kohli, and P. Wallace Low dose rabbit anti-thymoglobulin induction therapy results in prolonged selective CD4 T cell depletion irrespective of maintenance immunosuppression Am J Transplant 10 2010 316
21. T.F. Muller, S.O. Grebe, and M. Neumann Persistent long-term changes in lymphocyte subsets induced by polyclonal antibodies Transplantation 64 1997 1432
22. M.R. Laftavi, R. Kode, and K. Phillips Old kidney for old recipient: is it justified? Am J Transplant 1 2001 307
23. J.S. Cameron Renal transplantation in the elderly Int Urol Nephrol 32 2000 193